This article covers the structural pharmacology of both compounds, their distinct mechanisms of action at the receptor level, dosing and stability considerations that affect experimental design, and the specific research contexts where one clearly outperforms the other
The pharmacokinetics of sitagliptin was generally similar in healthy subjects and in patients with type 2 diabetes mellitus
Renk, MD, who is board-certified in anesthesiology and interventional pain management, and Gavin Nixon, DO, who is board-certified in Physical Medicine & Rehabilitation, offer glutathione infusion therapy as part of a comprehensive wellness and recovery program
He et al., 2011
Improve metabolism and blood sugar control
Are compounded medications FDA-approved